跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 60,731 条关于
“Théa Open Innovation”
全部
60,731
临床试验
49,375
药物
133
机构
217
资讯
11,006
6个月前
Galimedix Achieves Phase 1 Milestone for Oral GAL-101 in Alzheimer's Disease Development
去年
Kiora Pharmaceuticals Receives IND Approval for KIO-301 Phase 2 Trial in Retinitis Pigmentosa
去年
Kiora Pharmaceuticals Partners with Senju for KIO-301 Development in Asian Markets Worth Over $110 Million
去年
Kiora Pharmaceuticals Receives IND Approval for KIO-301 Phase 2 Retinitis Pigmentosa Trial
去年
OliX and Eli Lilly Forge $630M Deal for Novel RNAi Therapy Targeting MASH and Obesity
去年
Kiora Pharmaceuticals Advances Retinal Disease Pipeline with Positive Q3 Results
去年
Kiora Pharmaceuticals Advances Two Phase 2 Retinal Disease Trials, Secures $110M Asian Partnership
9个月前
Chugai Pharmaceutical Establishes U.S. Partnering Office to Accelerate Global Open Innovation Strategy
去年
Handok's Open Innovation Strategy Drives New Drug Development and Global Expansion
去年
Vevizye (Ciclosporin 0.1%) Receives European Commission Approval for Dry Eye Disease
第 1 页,共 1101 页
上一页
下一页